David Almaguer: Don’t forget that HSCT cures patients

David Almaguer, Professor of Hematology at Autonomous University of Nuevo León (UANL), shared on X/Twitter:

“Two interesting patients. On the right, three years after transplant, on the left, six months after transplant. Both suffering from myelofibrosis. Ruxolitinib was not enough. Don’t forget that HSCT cures patients.”

Source: David Almaguer/X